Key result
Morbid obesity is not associated with worse perioperative morbidity or mortality in robotic cardiac surgery.
Why the study?
Morbid obesity usually confers a higher perioperative risk in cardiac surgery, and robotic cardiac surgery may offer advantages for these high-risk patients.
Does morbid obesity (BMI ≥ 35 kg/m²) increase morbidity or in-hospital mortality in patients undergoing robotic cardiac surgery compared to non-morbidly obese patients?
Cohort (n=486)
No
Does morbid obesity (BMI ≥ 35 kg/m²) increase morbidity or in-hospital mortality in patients undergoing robotic cardiac surgery compared to non-morbidly obese patients?
Robotic cardiac surgery can be performed across a broad range of procedures in morbidly obese patients without increasing perioperative morbidity, length of stay, or in-hospital mortality.
Answers are grounded in this paper and cite their sources.
May support robotic cardiac surgery in morbidly obese patients; leaves open prospective validation before wider adoption.
OBJECTIVE: Morbid obesity (body mass index ≥ 35 kg/m) usually confers a higher perioperative risk in cardiac surgery. Robotic cardiac surgery may have many advantages for these high-risk patients. METHODS: We retrospectively reviewed patients undergoing robotic cardiac surgery from July 2013 to April 2017 at our institution. We compared the outcomes of morbidly obese patients versus nonobese patients. RESULTS: A total of 486 patients underwent robotic cardiac surgery (322 men, median age = 65 years). The robotic procedures were the following: totally endoscopic beating heart coronary artery bypass (n = 263), mitral valve surgery (n = 138), arrhythmia surgery (n = 33), adult congenital surgery (n = 16), pericardiectomy (n = 11), and others (n = 25). The cohorts were divided into the following: normal weight (body mass index < 25, n = 123), overweight (body mass index = 25 to < 30, n = 182), obesity (body mass index = 30 to < 35, n = 105), and morbid obesity (body mass index ≥ 35, n = 76). Morbidly obese patients had a higher rate of hypertension, dyslipidemia, and diabetes mellitus compared with normal or overweight patients. There were no significant differences in morbidity, mean length of intensive care unit stay (2.10 ± 4.27 days), and hospital stay (4.48 ± 5.61 days) among the groups. In-hospital mortality was 1.4% (7/486) with nonsignificant difference. CONCLUSIONS: Outcomes of robotic heart surgery in morbidly obese patients in our center were acceptable. Over a broad range of cardiac surgical procedures, morbid obesity was not associated with increased morbidity or mortality when these procedures were performed using a robotic approach. These findings can be beneficial in managing this challenging group of patients.
No takes yet. Share an insight, caveat, or question.
Kitahara et al. (2017) conducted a cohort in Patients undergoing robotic cardiac surgery across BMI categories (n=486). Morbid obesity (BMI ≥ 35 kg/m²) vs. Normal weight (BMI < 25), overweight (BMI 25 to < 30), and obesity (BMI 30 to < 35) was evaluated on In-hospital mortality and perioperative morbidity. Morbid obesity (BMI ≥35) was not associated with increased morbidity, ICU stay, or in-hospital mortality in robotic cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: